Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2008 | 1 |
2012 | 2 |
2013 | 1 |
2014 | 1 |
2015 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
The tumor microenvironment and its role in promoting tumor growth.
Oncogene. 2008 Oct 6;27(45):5904-12. doi: 10.1038/onc.2008.271.
Oncogene. 2008.
PMID: 18836471
Free PMC article.
Review.
Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.
Szczepanski MJ, Luczak M, Olszewska E, Molinska-Glura M, Zagor M, Krzeski A, Skarzynski H, Misiak J, Dzaman K, Bilusiak M, Kopec T, Leszczynska M, Witmanowski H, Whiteside TL.
Szczepanski MJ, et al.
J Mol Med (Berl). 2015 Mar;93(3):305-14. doi: 10.1007/s00109-014-1217-3. Epub 2014 Nov 12.
J Mol Med (Berl). 2015.
PMID: 25385222
Free PMC article.
Item in Clipboard
Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
Strauss L, Bergmann C, Whiteside TL.
Strauss L, et al.
Int J Cancer. 2007 Dec 1;121(11):2473-83. doi: 10.1002/ijc.23001.
Int J Cancer. 2007.
PMID: 17691114
Free article.
Item in Clipboard
PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.
Szczepanski MJ, DeLeo AB, Łuczak M, Molinska-Glura M, Misiak J, Szarzynska B, Dworacki G, Zagor M, Rozwadowska N, Kurpisz M, Krzeski A, Kruk-Zagajewska A, Kopec T, Banaszewski J, Whiteside TL.
Szczepanski MJ, et al.
Oral Oncol. 2013 Feb;49(2):144-51. doi: 10.1016/j.oraloncology.2012.08.005. Epub 2012 Sep 1.
Oral Oncol. 2013.
PMID: 22944049
Free PMC article.
Item in Clipboard
17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.
Szajnik M, Szczepanski MJ, Elishaev E, Visus C, Lenzner D, Zabel M, Glura M, DeLeo AB, Whiteside TL.
Szajnik M, et al.
Gynecol Oncol. 2012 Dec;127(3):587-94. doi: 10.1016/j.ygyno.2012.08.010. Epub 2012 Aug 17.
Gynecol Oncol. 2012.
PMID: 22903146
Free PMC article.
Item in Clipboard
Cite
Cite